GTS-21, a nicotinic agonist, protects against neocortical neuronal cell loss induced by the nucleus basalis magnocellularis lesion in rats

Japanese Journal of Pharmacology

Volumn 74, Issue 3, 1997, Pages 285-289

  Nanri, Masato ^a,b   Kasahara, Nobuo ^a   Yamamoto, Jyunji ^a   Miyake, Hidekazu ^a   Watanabe, Hiroshi ^b  

^a TAIHO PHARMACEUTICAL CO LTD   (Japan)

^b UNIVERSITY OF TOYAMA   (Japan)

Author keywords

GTS 21; Neuronal cell loss; Nicotinic agonist

Indexed keywords

3 (2,4 DIMETHOXYBENZYLIDENE)ANABASEINE; NEUROPROTECTIVE AGENT; NICOTINE; NICOTINIC AGENT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL LOSS; CONTROLLED STUDY; MAGNOCELLULAR NUCLEUS; MALE; NERVE CELL; NEUROPROTECTION; NONHUMAN; OLIVARY NUCLEUS; ORAL DRUG ADMINISTRATION; PARIETAL LOBE; RAT;

EID: 0030859444     PISSN: 00215198     EISSN: None     Source Type: Journal    
DOI: 10.1254/jjp.74.285     Document Type: Article

References (15)

1. Whitehouse PJ, Price DL, Clark AW, Coyle JT and DeLong MR: Alzheimer disease: evidence for selective loss of cholinergic neurons in the nucleus basalis. Ann Neurol 10, 122-126 (1981)
2. Schröder H, Giacobini E, Struble RG, Zilles K and Maelicke A: Nicotinic cholinoceptive neurons of the frontal cortex are reduced in Alzheimer's disease. Neurobiology of Aging 12, 259-262 (1991)
3. Newhouse PA, Sunderland T, Tariot PN, Blumhardt CL, Weingartner H, Mellow A and Murphy DL: Intravenous nicotine in Alzheimer's disease: a pilot study. Psychopharmacology (Berlin) 95, 171-175 (1988)
4. Meyer EM, deFiebre CM, Hunter BE, Simpkins CE, Frauworth N and de Fiebre NEC: Effects of anabaseine-related analogs on rat brain nicotinic receptor binding and on avoidance behaviors. Drug Dev Res 31, 127-134 (1994)
5. Martin EJ, Panickar KS, King MA, Deyrup M, Hunter BE, Wang G and Meyer EM: Cytoprotective action of 2,4-dimethoxybenzylidene anabaseine in differentiated PC12 cells and septal cholinergic neurons. Drug Dev Res 31, 135-141 (1994)
6. Roßner S, Schliebs R and Bigl V: Ibotenic acid lesion of nucleus basalis magnocellularis differentially affects cholinergic, glutamatergic and GABAergic makers in cortical rat brain regions. Brain Res 668, 85-99 (1994)
7. Wellman CL and Sengelaub DR: Cortical neuroanatomical correlates of behavioral deficits produced by lesion of the basal forebrain in rats. Behav Neural Biol 56, 1-24 (1991)
8. Paxinos G and Watson C: The Rat Brain in Stereotaxic Coordinates, Second Ed, Academic Press Inc, New York (1986)
9. Zoltewicz JA, Prokai-Tatrai K, Bloom LB and Kem WR: Long range transmission of polar effects in cholinergic 3-arylidene anabaseines. Conformations calculated by molecular modelling. Heterocycles 35, 171-179 (1993)
10. Arendash GW, Millard WJ, Dunn AJ and Meyer EM: Long-term neuropathological and neurochemical effects of nucleus basalis lesions in the rat. Science 238, 952-956 (1987)
11. 3H]GABA uptake in nucleus basalis lesioned rats. Brain Res 624, 295-298 (1993)
12. Terry JAV and Clarke MSF: Nicotine stimulation of nerve growth factor receptor expression. Life Sci 55, 91-98 (1994)
13. Nitta A, Murase K, Furukawa Y, Hayashi K, Hasegawa T and Nabeshima T: Effects of oral administration of a stimulator for nerve growth factor synthesis in basal forebrain-lesioned rats. Eur J Pharmacol 250, 23-30 (1993)
14. Bhagat B, Bayer T and Lind C: Effects of chronic administration of nicotine on drug-induced hypnosis in mice. Psychopharmacologia 21, 287-293 (1971)
15. 125I-α-bungarotoxin receptor subtypes. Mol Pharmacol 47, 164-171 (1995)